Who owns Cubist Pharmaceuticals?

Key details on Cubist Pharmaceuticals (Ticker: CBST)

Who owns Cubist Pharmaceuticals?

Is CBST a good stock to own? Find out who bought Cubist Pharmaceuticals, who sold Cubist Pharmaceuticals (CBST) stock, and who holds a large position in Cubist Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
BNP PARIBAS ARBITRAGE, SNC 8.05M $1.96B Dec. 31, 2013
FMR 7.24M $498.42M Dec. 31, 2013
Wellington Management Company 6.55M $416.44M Sept. 30, 2013
PUTNAM INVESTMENTS 5.41M $372.47M Dec. 31, 2013
Vanguard 4.33M $298.25M Dec. 31, 2013
BlackRock Fund Advisors 2.87M $197.65M Dec. 31, 2013
Westfield Capital Management Company 2.70M $186.19M Dec. 31, 2013
T. Rowe Price Associates 2.49M $171.59M Dec. 31, 2013
Canada Pension Plan Investment Board 2.34M $161.11M Dec. 31, 2013
Federated Investors 2.31M $158.82M Dec. 31, 2013
Damian Sousa 2.25M $154.89M Dec. 31, 2013
Barclays 2.18M $148.31M Dec. 31, 2013
STATE STREET CORPORATION 2.04M $140.37M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.98M $136.32M Dec. 31, 2013
CALAMOS ADVISORS 1.92M $91.40M Sept. 30, 2012
HealthCor Management 1.90M $68.38M June 30, 2011
HAP Trading 1.90M $2.46M Dec. 31, 2013
Wells Fargo & Company 1.40M $89.17M Sept. 30, 2013
HealthCor Management 1.40M $96.42M Dec. 31, 2013
Deerfield Management Company 1.39M $95.47M Dec. 31, 2013
S.A.C. Capital Advisors 1.34M $57.99M March 31, 2012
Palo Alto Investors 1.34M $92.02M Dec. 31, 2013
Columbus Circle Investors 1.33M $57.67M March 31, 2012
Charles Schwab Bank 1.27M $27.15M March 31, 2013
ALLIANCEBERNSTEIN 1.23M $85.04M Dec. 31, 2013
Millennium Management 1.23M $78.44M Sept. 30, 2013
Deutsche Bank Aktiengesellschaft 1.12M $77.16M Dec. 31, 2013
PointState Capital 1.10M $53.12M June 30, 2013
Name Goodman & Company, Investment Counsel 1.10M $47.23M March 31, 2012
CITADEL ADVISORS 1.03M $43.21M Dec. 31, 2012
GRANAHAN INVESTMENT MANAGEMENT INC/MA 1.01M $40.04M Dec. 31, 2011
Inves 998245 $46.74M March 31, 2013
Rainier Investment Management 971150 $46.30M Sept. 30, 2012
Sabretooth Capital Management 959600 $24.22M March 31, 2011

Who sold Cubist Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
FRED ALGER MANAGEMENT Sept. 30, 2011 1.35M $47.62M
Expo Capital Management June 30, 2011 1000000 $35.99M
Sabretooth Capital Management March 31, 2011 959600 $24.22M